HAEMATOLOGICA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2024-03-18 ms8000001608810099 来自山东省

投稿命中率:25.0
经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了

21 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2021-12-11 ms8000001693143278

审稿速度:1.0 | 投稿命中率:25.0
经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？

148 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2023-04-05 ms7000000977140127 来自浙江省

偏重的研究方向：形态学;血液学
经验分享：还可以

87 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2023-01-03 laowull 来自广东省

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：机制
经验分享：速度快

99 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2023-07-25 阿金来自山东省

审稿速度:6.0
经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。

124 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2022-06-12 ms5000000961898741

偏重的研究方向：血液肿瘤
经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分

122 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2023-06-07 ms3000000801253382 来自天津

状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗

89 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2021-08-13 ms3000000476544855

请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解

212 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2022-06-02 ms8000001231427569

请问审稿费在哪里交啊！！！救救孩子吧

122 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193793, encodeId=c6132193e9368, content=投稿命中率:25.0 经验分享：请问大家状态是Under Review，点进去status是decision made and waiting to be processed，是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Mon Mar 18 09:13:19 CST 2024, time=2024-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1079152, encodeId=a34910e915257, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：请教一下 under review没几天，状态称为 decision made and waiting to be processed是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e636398083, createdName=ms8000001693143278, createdTime=Sat Dec 11 23:16:22 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123856, encodeId=b01d2123856b0, content=偏重的研究方向：形态学;血液学 经验分享：还可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5472345, createdName=ms7000000977140127, createdTime=Wed Apr 05 10:15:48 CST 2023, time=2023-04-05, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108648, encodeId=74002108648c2, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：机制 经验分享：速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pgibWWq6lw9mQLiadcSKibZfSql2poBy8RI4UntnosWA0AKicUCAgJVoa3AEgafq8GmMUej8ohAsDao7EsC2kpsficA/132, createdBy=e6841986309, createdName=laowull, createdTime=Tue Jan 03 17:29:03 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2149705, encodeId=ca592149e058a, content=审稿速度:6.0 经验分享：血液学基础研究，2023年一月投稿，七月接收。第一次修回，两个审稿人，共11个Major comments，一堆Minor concerns. 三个月补充实验，认真回答每个审稿人的问题，压线修回。第二次修回，只有一个问题，关于文章中Stem cell Marker的参考文献，添加了2篇参考文献。第三次修回主要修改格式，然后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=390c1662916, createdName=阿金, createdTime=Tue Jul 25 08:58:22 CST 2023, time=2023-07-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225923, encodeId=c5d7122592332, content=偏重的研究方向：血液肿瘤 经验分享：刚刚接收一篇基础研究论著。总体来说比较难投的杂志，我们实验室几乎每年都会投一篇到haematologica，上一次中article还是8年前，这次的文章也是做了接近4年，blood被拒后转投，2021年11月5日投稿，一个半月后收到major change，共10个问题左右，补实验历时5个月返回，1周接收，reviewer均表示没有问题，总历时8个月。haematologica整体来说文章质量还是很高的，我个人认为高于JHO和BCJ，在国外的认可度也高，只是国内投的人确实少，影响因子也不温不火，但是还是希望今年能上10分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4368177112, createdName=ms5000000961898741, createdTime=Sun Jun 12 08:44:03 CST 2022, time=2022-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141224, encodeId=4a572141224c6, content=状态是 Under Review (waiting for reviewers to accept) (additional suggestions requested)，需要进一步提供reviewers吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e19b8296362, createdName=ms3000000801253382, createdTime=Wed Jun 07 09:52:31 CST 2023, time=2023-06-07, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1007571, encodeId=4950100e571ed, content=请问大家有遇到 Under Review (additional suggestions requested)这个状态么？求解, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4aa5546346, createdName=ms3000000476544855, createdTime=Fri Aug 13 12:00:46 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224148, encodeId=799212241486c, content=请问审稿费在哪里交啊！！！救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb478148000, createdName=ms8000001231427569, createdTime=Thu Jun 02 21:10:59 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531139, encodeId=ab9f531139a1, content=请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d35162890, createdName=lzo19880306, createdTime=Tue Dec 27 16:54:00 CST 2016, time=2016-12-27, status=1, ipAttribution=)]

2016-12-27 lzo19880306

请问各位大神，投稿成功后的状态应该是怎么样的？怎么没有收到杂志社发来的确认邮件呢？已经交了审稿费了。谢谢

428 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务